CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Endpoints News
Original article

French gene therapy biotech gets €33M to follow Krystal's blueprint

Positive
AI Analysis

Summary

Cyllene Therapeutics raised €33M to develop HSV-based gene therapies, following Krystal Biotech's approach in a different therapeutic area.

Importance:5/10
Sentiment:
0.60
gene therapyHSV-basedfundingFrancebiotech
Related Companies

Read the original article

Published by Endpoints News on July 7, 2026 5:30 AM

Read Original